Stockreport

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements [Yahoo! Finance]

TransCode Therapeutics, Inc.  (RNAZ) 
PDF BOSTON Jan. 7, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therap [Read more]